Targeted Radionuclide Therapy With Astatine-211: Oxidative Dehalogenation of Astatobenzoate Conjugates

Scientific Reports - United Kingdom
doi 10.1038/s41598-017-02614-2
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Development of Reagents for Application of At-211 to Targeted Radionuclide Therapy of Cancer

2011English

Targeted Radionuclide Therapy

Journal of Labelled Compounds and Radiopharmaceuticals
Organic ChemistryNuclear MedicineRadiologyBiochemistryAnalytical ChemistryImagingSpectroscopyDrug Discovery
2007English

Pretargeting of Astatine-211 for Therapy of Metastic Prostate Cancer

1999English

Targeted Alpha Therapy With Astatine-211-Labeled Anti-Psca A11 Minibody Shows Antitumor Efficacy in Prostate Cancer Xenografts and Bone Microtumors

EJNMMI Research
Nuclear MedicineRadiologyImaging
2020English

Realizing Clinical Trials With Astatine-211: The Chemistry Infrastructure

Cancer Biotherapy and Radiopharmaceuticals
Nuclear MedicineRadiologyPharmacologyCancer ResearchOncologyImagingMedicine
2020English

Introduction to Radiobiology of Targeted Radionuclide Therapy

Frontiers in Medicine
Medicine
2015English

Global Trends Survey for Targeted Radionuclide Therapy

Nippon Hoshasen Gijutsu Gakkai zasshi
Medicine
2018English

Dispersal Rates of Astatine-211 From Aqueous Solutions and Chloroform

Radiation Safety Management
2019English

Terbium-161 for PSMA-targeted Radionuclide Therapy of Prostate Cancer

European Journal of Nuclear Medicine and Molecular Imaging
MedicineNuclear MedicineRadiologyImaging
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy